Drug Target Review: Potential target found for tuberous sclerosis complex
A study on tuberous sclerosis complex has expanded the knowledge of the formation of this disease and how it can be targeted at the molecular level.
These findings were published in the jounal Nature Metabolism.
Related Stories
Mayor Pureval, Rob Richardson lead ethical AI symposium
July 5, 2024
As artificial intelligence rapidly integrates into everyday life, Rob Richardson, CEO and founder of Disrupt Now and MidwestCon and local tech startup partner of the University of Cincinnati 1819 Innovation Hub, recently spearheaded the Responsible AI Symposium with Cincinnati Mayor Aftab Pureval, calling upon community leaders to discuss and ensure artificial intelligence technologies help users rather than harm.
UC’s microchip training includes innovative VR
July 2, 2024
To build a virtual microchip factory, University of Cincinnati doctoral students turned to the real one where they work. UC launched a new training program for microchip manufacturing in advance of the new fabrication plant Intel Corp. is opening in Ohio.
University-wide Qualtrics license coming soon
July 2, 2024
The new university-wide Qualtrics license will provide current UC students, faculty, and staff members access to Qualtrics software, support, and technical assistance under a centralized license.